House hearing focuses on biotech benefits

House hearing focuses on biotech benefits

Better communication on direct benefits of biotechnology needed to turn tide of negative consumer perceptions.

BIOTECHNOLOGY, specifically genetically modified organisms (GMOs), has come under fire in recent years, but a congressional hearing carried a much different message about the positive societal benefits of biotechnology.

In a July 9 House Agriculture Committee hearing, a main topic for the legislators and witnesses was a failure to accurately communicate the benefits of biotechnology.

Cornell University professor David Just,

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.